MPhA News

Small Doses

March 27

As a reminder, the MPhA website is not optimized for Internet Explorer. We recommend the use of Chrome or Firefox.

News from MPhA

Mission Moments

COP Donates PPE to Clinical/Health Care Operations

The University of Minnesota College of Pharmacy was among the research labs that stepped up to provide personal protective equipment (PPE) to the University’s COVID-19 clinical and health care operations. Tens of thousands of pairs of gloves, hundreds of N-95 masks, gowns, and boxes of swabs and disinfecting wipes have been donated.

PPE Collected at UMN

In Memoriam: Dr. Donald Uden

Dr. Donald Uden

Don Uden, PharmD, FCCP, a MPhA member who was a Distinguished University Teaching Professor at the University of Minnesota College of Pharmacy, passed away unexpectedly on March 21. He was 67. Dr. Uden was part of the COP for more than 30 years, most recently serving as professor in the Department of Pharmaceutical Care & Health Systems.

Don is survived by his daughter Jamie (Dan) Vargo, three granddaughters, Abigail, Madelyn and Lillian, his partner Brenda Trebesch, his mother Jean Snare and many half-sisters and brothers. He is preceded in death by his father Rudy Uden; his stepmother Gloria Uden; his stepfather Daniel Snare; his brother Doug; his half-sister Denise and his half-brother Dale.

The COP is working with Dr. Uden’s family to determine the most appropriate way to honor his contributions. In lieu of flowers, memorial contributions may be made to the Hadsell-Uden Fund for Pharmacy Advancement online at z.umn.edu/Hadsall-Uden (click “special options” to add “in memory of Don Uden”). You can also mail a check made out to the “U of M Foundation” with “#22899 in memory of Don Uden” in the memo line; send to U of M Foundation, P.O. Box 860266, Minneapolis, MN, 55486-0266. Read the full tribute.

MPhA Needs Your Help

How Is COVID-19 Affecting Your Practice?

MPhA wants to hear from our members! How has your company and/or your practice been affected by COVID-19? Email your thoughts to COVID19@mpha.org. Watch for a quick 8-question survey in an email next week.


Reminder: COVID-19 Resources

MPhA has created a landing page on our website for updates and resources on COVID-19. Should you have any questions or suggestions on resources that we can add to our website, please email COVID19@mpha.org. MPhA is also holding weekly webinars for members so we can discuss what others are doing and all assist each other during this time. Visit the page at https://www.mpha.org/page/covid-19

APMS

Minnesota News

State Waivers to Deal with COVID-19

Under the Governor’s Emergency Executive Order 20-12, the Minnesota Department of Human Services has temporary authority to waive or modify requirements to continue providing essential programs and services. Among them:

  • Preserving health care coverage for Children’s Health Insurance Program, Medical Assistance and Minnesota Care, so that enrollees only lose coverage if they request an end to coverage or move out of Minnesota.
  • Allowing phone or Internet visits for waiver programs (including some requirements for face-to-face visits for seniors and people with disabilities who receive long-term services and supports).

Read the full guidance.


Submit a Presentation for Minnesota Academy of Physician Assistants

The Minnesota Academy of Physician Assistants (MAPA) has a new process for selecting presenters for its CME events. To be considered either for the 2020 Pharmacotherapy Review meeting (which is scheduled for May 15 in Mankato) or at one of the multi-day meetings, you can now complete an online form.

National News

Pharmacists Involved in First Human Clinical Trial for COVID-19 Vaccine

From World Economic Forum website, March 17: The first human clinical trial of a potential COVID-19 vaccine was administered recently. Four volunteers received their first shots, with 45 volunteers expected to participate in the trial. The vaccine won’t be available to the general public for at least a year to see if it is both safe and effective. Read the full article.
COVID-19 Vaccine Trial

Pharmacist Michael Witte is among those involved in the clinical trial at the Kaiser Permanente Washington Health Research Institute in Seattle.


Congressional Members Urge Action on DIR Fees

From National Community Pharmacists Association, March 24: More than 50 members of Congress urged U.S. House and Senate leaders to consider pausing DIR fees on pharmacies for the remainder of 2020, and ensuring the fees prohibited during this time are not assessed on pharmacies after the pandemic has ended. Read the full letter.


Pharmacist Advocacy Groups Call for Action to Enhance COVID-19 Patient Care

From National Alliance of State Pharmacy Associations, March 20: The National Alliance of State Pharmacy Associations (NASPA) and 11 other organizations representing the interests of all pharmacists in the U.S. have released a joint set of policy recommendations critical to addressing the COVID-19 pandemic. Read the full article.


FDA Updates 503B Bulk List

From Alliance for Pharmacy Compounding, March 24: The U.S. Food & Drug Administration has released a new 503B bulk list that adds Hydroxychloroquine Sulfate to category 1. Hyaluronidase has been removed from category 1. Read the full update.


DEA Postpones National Prescription Drug Take Back Day

Due to ongoing safety concerns over COVID-19, the U.S. Drug Enforcement Administration (DEA) has cancelled the National Prescription Drug Take Back Day that was scheduled for April 25. The DEA hopes to schedule a Take Back Day for October 2020. In the meantime, the DEA notes that many permanent disposal kiosks are located throughout the nation so that people can continue to safely dispose of unwanted prescription drugs during the pandemic. Check out the National Association of Boards of Pharmacy (NABP) Drug Disposal Locator Tool to get up-to-date information.

MPhA Events

Register Now! MPhA Virtual Town Hall: Long-Acting Injectables

Tuesday, April 7 • 6-7:30 p.m. • Presenters: Amie Jo Digatono, PharmD, BCPP, and Julie Jackman, PharmD, BC-ACP

A review of the FDA-approved indications and the use of long-acting injectable (LAI) antipsychotics and extended-release naltrexone in the appropriate patient populations. Mechanism of action, dosing, need for oral medication overlap, and potential adverse effects will be explored. Participants will compare and contrast the different long-acting injectable antipsychotics and identify which agent(s) may be most appropriate based on patient and product characteristics. Participants will identify patients who may benefit from extended-release naltrexone and when initiation of extended-release naltrexone is appropriate. Finally, participants will be able to list advantages and disadvantages to the use of long-acting injectable antipsychotics and extended-release naltrexone to identify possible motivations for patient acceptance of these agents.

Amie Jo Digatono, PharmD, graduated from the University of Minnesota College of Pharmacy in 2011. She is a Board-Certified Psychiatric Pharmacist with experience treating patients with severe and persistent mental illness in a state behavioral health hospital and in a community hospital inpatient unit. Her experience also includes caring for patients with substance use disorders as well as dual diagnosis patients (those with co-occurring behavioral health and substance use disorders). She enjoys volunteering at the University of Minnesota College of Pharmacy, serving as a peer reviewer for the College of Psychiatric and Neurologic Pharmacists, and working as an election judge with the city of Minneapolis.

Julie Jackman is a doctor of pharmacy and Board Certified in Ambulatory Care. A 1999 graduate of the University of Pittsburgh, she has been practicing in mental health since 2008. Dr. Jackman has a holistic view when treating her patients, thanks to previous experience in community pharmacy, with additional training in diabetes and immunizations. Mental illness can impede a patient’s ability to care for themselves. Dr. Jackman strives to ensure her patients don’t fall through the cracks. Her unique practice was recognized in Pharmacy Today, a national pharmacy magazine, in 2009. Also in 2009, she was named Minnesota’s Distinguished Young Pharmacist. She was one of the original 512 pharmacists in the U.S. to earn the Board Certified Ambulatory Care Pharmacist (BC-ACP) designation in 2011. In 2014, she received the Individual Immunization Champion Award from the American Pharmacists Assocation (APhA) for her work in helping increase vaccination rates in the mental health population.


Register Now! APhA’s Delivering Medication Therapy Management Services

Friday, May 8 • 8 a.m.-5 p.m. • Facilitators: Jordan Wolf, PharmD, and Michelle Johnson, PharmD, BCACP • St. Paul

Join us for the next MTM certificate program in May. This program qualifies you to register as a provider with MN Medicaid and conduct and receive payment for Medication Therapy Management services. Seats are limited, so register today!

APhA’s Delivering Medication Therapy Management Services Certificate training program (3rd Edition) presents a systematic approach for developing, implementing, delivering, and sustaining MTM services. It includes an overview of the marketplace for delivering MTM services, guidance for implementing MTM services in pharmacy practice, a review of the essential skills and knowledge needed for performing MTM successfully, and an organized process for identifying medication-related problems. The purpose of this certificate training program is to prepare pharmacists to improve medication use through the delivery of MTM services in a variety of practice settings.

Learn more and register now!


MSHP and MPhA Joint CE Event: Central Minnesota Resident Clinical Pearls 2020

Thursday, April 2, 5-7:30 p.m. • Courtyard by Marriott, St. Cloud

MPhA is pleased to partner with the Minnesota Society of Health-System Pharmacists to present Central Minnesota Resident Clinical Pearls. MPhA members may attend at no cost.

RSVP now!


MPhA Virtual Coffee Break: Payment Opportunities for Pharmacist-Delivered Patient Care

Wednesday, May 20, 11:30 a.m.-12:30 p.m. • Online Webinar

Steven Simenson, BPharm, FAPhA, FACA, DPNAP, is the CEO and Managing Partner of Goodrich Pharmacy, Inc., with five pharmacies in Minnesota. He is a graduate of the University of Minnesota College of Pharmacy, where he now serves as an adjunct faculty member. Steve was the 2013-2014 President of the American Pharmacists Association and is on the Board of Directors of Pharmacists Mutual Insurance Companies. He is past-president and founder of the Minnesota Pharmacists Foundation and past-president of the Minnesota Pharmacists Association.

In 2019, he helped organize CPESN MN and serves as its Lead Luminarie. He currently serves on the Minnesota Pharmacy Alliance, the Minnesota Department of Health E-HIT Advisory Committee and is President of the APhA Foundation Board and a member of the Community Pharmacy Foundation Board. Steve serves as a leader for innovative practice initiatives in Community Pharmacy and Clinically Integrated Care, including Collaborative Practice, Medication Therapy Management, and Pharmacogenomics. He is actively advocating for the pursuit of Patient Access to and Coverage for Pharmacist Patient Care Services.
Register Now!

Register now!


Save the Dates: MPhA Events

May 21 • MPhA Virtual Town Hall: Long-Acting Injectables
June 10 • MPhA Leadership Summit and House of Delegates • Midland Hills Country Club, Roseville
June 16 • MPhA Town Hall: Long-Acting Injectables • Alexandria area
Sept. 8 • MPhA Town Hall: Long-Acting Injectables • Southwest Minnesota
Sept. 13 • MPhA Town Hall: Long-Acting Injectables • Mora area
Sept. 15 • MPhA Town Hall: Long-Acting Injectables • Duluth area

In this Issue

News from MPhA

Mission Moments

COP Donates PPE to Clinical/Health Care Operations

In Memoriam: Dr. Donald Uden

MPhA Needs Your Help

How Is COVID-19 Affecting Your Practice?

Reminder: COVID-19 Resources

Minnesota News

State Waivers to Deal with COVID-19

Submit a Presentation for Minnesota Academy of Physician Assistants

National News

Pharmacists Involved in First Human Clinical Trial for COVID-19 Vaccine

Congressional Members Urge Action on DIR Fees

Pharmacist Advocacy Groups Call for Action to Enhance COVID-19 Patient Care

FDA Updates 503B Bulk List

DEA Postpones National Prescription Drug Take Back Day


MPhA Events

Register Now! MPhA Virtual Town Hall: Long-Acting Injectables

Register Now! APhA’s Delivering Medication Therapy Management Services

MSHP and MPhA Joint CE Event: Central Minnesota Resident Clinical Pearls 2020

MPhA Virtual Coffee Break: Payment Opportunities for Pharmacist-Delivered Patient Care

Save the Date: MPhA Events


Contact Us

Administrative Office
info@mpha.org

Executive Director
sarahd@mpha.org